| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||||
| For the quarterly period ended | March 31, 2026 | |||||||
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |||||||
| For the transition period from ______ to ______ | ||||||||
| Commission file number | 1-10816 | |||||||

| Wisconsin | 39-1486475 | ||||||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||||||||
| 250 E. Kilbourn Avenue | 53202 | ||||||||||
| Milwaukee, | Wisconsin | (Zip Code) | |||||||||
| (Address of principal executive offices) | |||||||||||
| (414) | 347-6480 | ||||||||||
| (Registrant’s telephone number, including area code) | |||||||||||
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
| Common stock | MTG | New York Stock Exchange | ||||||||||||
| Large accelerated filer | ☒ | Accelerated filer ☐ | Non-accelerated filer ☐ | Smaller reporting company | ☐ | (Do not check if a smaller reporting company) | ||||||||||||||
| Emerging growth company | ☐ | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o | ||||||||||||||||||
Table of Contents | ||||||||
| Page | ||||||||
Consolidated Balance Sheets - March 31, 2026 (Unaudited) and December 31, 2025 | ||||||||
Consolidated Statements of Operations (Unaudited) - Three Months Ended March 31, 2026 and 2025 | ||||||||
Consolidated Statements of Comprehensive Income (Unaudited) - Three Months Ended March 31, 2026 and 2025 | ||||||||
Consolidated Statements of Shareholders’ Equity (Unaudited) - Three Months Ended March 31, 2026 and 2025 | ||||||||
Consolidated Statements of Cash Flows (Unaudited) - Three Months Ended March 31, 2026 and 2025 | ||||||||
| Item 2 | ||||||||
MGIC Investment Corporation and Subsidiaries | |||||||||||||||||||||||
Consolidated Balance Sheets | |||||||||||||||||||||||
| (In thousands) | Note | March 31, 2026 | December 31, 2025 | ||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||
Assets | |||||||||||||||||||||||
| Investment portfolio: | |||||||||||||||||||||||
| Fixed income, available-for-sale, at fair value (amortized cost 2026 - $5,677,277; 2025 - $5,642,929) | $ | 5,482,530 | $ | 5,489,945 | |||||||||||||||||||
| Short-term, fixed income, available-for-sale, at fair value (amortized cost 2026 - $220,684; 2025 - $301,072) | 220,591 | 301,286 | |||||||||||||||||||||
| Equity securities, at fair value (cost 2026 - $16,323; 2025 - $16,286) | 15,191 | 15,322 | |||||||||||||||||||||
| Other invested assets, at cost | 1,109 | 1,109 | |||||||||||||||||||||
| Total investment portfolio | 5,719,421 | 5,807,662 | |||||||||||||||||||||
| Cash and cash equivalents | 235,090 | 368,989 | |||||||||||||||||||||
| Restricted cash and cash equivalents | 14,405 | 6,525 | |||||||||||||||||||||
| Accrued investment income | 57,256 | 58,009 | |||||||||||||||||||||
| Reinsurance recoverable on loss reserves | 73,184 | 65,055 | |||||||||||||||||||||
| Reinsurance recoverable on paid losses | 3,897 | 4,386 | |||||||||||||||||||||
| Premiums receivable | 68,143 | 58,184 | |||||||||||||||||||||
| Home office and equipment, net | 31,947 | 32,454 | |||||||||||||||||||||
| Deferred insurance policy acquisition costs | 7,955 | 8,377 | |||||||||||||||||||||
| Deferred income taxes, net | 15,494 | 18,512 | |||||||||||||||||||||
| Other assets | 189,957 | 211,333 | |||||||||||||||||||||
Total Assets | $ | 6,416,749 | $ | 6,639,486 | |||||||||||||||||||
Liabilities and Shareholders’ Equity | |||||||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||
| Loss reserves | $ | 499,120 | $ | 474,884 | |||||||||||||||||||
| Unearned premiums | 92,606 | 93,026 | |||||||||||||||||||||
| Senior notes | 646,506 | 646,138 | |||||||||||||||||||||
Federal tax credits payable | 16,110 | 135,344 | |||||||||||||||||||||
| Other liabilities | 125,120 | 142,543 | |||||||||||||||||||||
Total Liabilities | 1,379,462 | 1,491,935 | |||||||||||||||||||||
| Contingencies | |||||||||||||||||||||||
| Shareholders’ equity: | |||||||||||||||||||||||
Common stock ($1 par value, shares authorized 1,000,000; shares issued and outstanding 2026 - 213,200; 2025 - 219,367) | 213,200 | 219,367 | |||||||||||||||||||||
| Paid-in capital | 1,795,697 | 1,812,463 | |||||||||||||||||||||
| Accumulated other comprehensive income (loss), net of tax | (167,482) | (134,394) | |||||||||||||||||||||
| Retained earnings | 3,195,872 | 3,250,115 | |||||||||||||||||||||
Total Shareholders’ Equity | 5,037,287 | 5,147,551 | |||||||||||||||||||||
Total Liabilities and Shareholders’ Equity | $ | 6,416,749 | $ | 6,639,486 | |||||||||||||||||||
MGIC Investment Corporation and Subsidiaries | |||||||||||||||||||||||
Consolidated Statements of Operations (Unaudited) | |||||||||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||||||||
| (In thousands, except per share data) | Note | 2026 | 2025 | ||||||||||||||||||||
| Revenues: | |||||||||||||||||||||||
| Premiums written: | |||||||||||||||||||||||
| Direct | $ | 286,522 | $ | 276,471 | |||||||||||||||||||
| Assumed | 3,965 | 3,538 | |||||||||||||||||||||
| Ceded | (55,544) | (44,663) | |||||||||||||||||||||
| Net premiums written | 234,943 | 235,346 | |||||||||||||||||||||
| Decrease in unearned premiums, net | 420 | 8,373 | |||||||||||||||||||||
| Net premiums earned | 235,363 | 243,719 | |||||||||||||||||||||
| Investment income, net of expenses | 61,742 | 61,443 | |||||||||||||||||||||
| Net gains (losses) on investments and other financial instruments | (169) | 741 | |||||||||||||||||||||
| Other revenue | 141 | 331 | |||||||||||||||||||||
Total Revenues | 297,077 | 306,234 | |||||||||||||||||||||
Losses and Expenses: | |||||||||||||||||||||||
| Losses incurred, net | 33,242 | 9,591 | |||||||||||||||||||||
Amortization of deferred insurance policy acquisition costs | 1,224 | 1,657 | |||||||||||||||||||||
| Other underwriting and operating expenses, net | 46,884 | 51,406 | |||||||||||||||||||||
| Interest expense | 8,899 | 8,899 | |||||||||||||||||||||
Total Losses and Expenses | 90,249 | 71,553 | |||||||||||||||||||||
| Income before tax | 206,828 | 234,681 | |||||||||||||||||||||
| Provision for income tax | 41,525 | 49,221 | |||||||||||||||||||||
Net Income | $ | 165,303 | $ | 185,460 | |||||||||||||||||||
| Earnings per share: | |||||||||||||||||||||||
| Basic | $ | 0.76 | $ | 0.76 | |||||||||||||||||||
| Diluted | $ | 0.76 | $ | 0.75 | |||||||||||||||||||
| Weighted average common shares outstanding - basic | 216,135 | 244,147 | |||||||||||||||||||||
| Weighted average common shares outstanding - diluted | 218,186 | 246,490 | |||||||||||||||||||||
MGIC Investment Corporation and Subsidiaries | ||||||||||||||||||||
Consolidated Statements of Comprehensive Income (Unaudited) | ||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||
| (In thousands) | Note | 2026 | 2025 | |||||||||||||||||
Net Income | $ | 165,303 | $ | 185,460 | ||||||||||||||||
| Other comprehensive income (loss), net of tax: | ||||||||||||||||||||
| Change in unrealized investment gains and losses | (33,238) | 51,671 | ||||||||||||||||||
| Benefit plan adjustments | 150 | 46 | ||||||||||||||||||
| Other comprehensive income (loss), net of tax | (33,088) | 51,717 | ||||||||||||||||||
Comprehensive Income (Loss) | $ | 132,215 | $ | 237,177 | ||||||||||||||||
MGIC Investment Corporation and Subsidiaries | ||||||||||||||||||||
Consolidated Statements of Shareholders' Equity (Unaudited) | ||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||
| (In thousands) | Note | 2026 | 2025 | |||||||||||||||||
Common Stock | ||||||||||||||||||||
Balance, beginning of period | $ | 219,367 | $ | 248,449 | ||||||||||||||||
| Issuance of common stock, net under share-based compensation plans | 1,042 | 980 | ||||||||||||||||||
Purchases of common stock | (7,209) | (9,235) | ||||||||||||||||||
| Balance, end of period | 213,200 | 240,194 | ||||||||||||||||||
Paid-in Capital | ||||||||||||||||||||
| Balance, beginning of period | 1,812,463 | 1,808,236 | ||||||||||||||||||
| Issuance of common stock, net under share-based compensation plans | (23,197) | (19,848) | ||||||||||||||||||
| Equity compensation | 6,431 | 8,087 | ||||||||||||||||||
| Balance, end of period | 1,795,697 | 1,796,475 | ||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||
| Balance, beginning of period | (134,394) | (288,162) | ||||||||||||||||||
| Other comprehensive income (loss), net of tax | (33,088) | 51,717 | ||||||||||||||||||
| Balance, end of period | (167,482) | (236,445) | ||||||||||||||||||
Retained Earnings | ||||||||||||||||||||
| Balance, beginning of period | 3,250,115 | 3,403,852 | ||||||||||||||||||
Purchases of common stock | (187,007) | (217,104) | ||||||||||||||||||
| Net income | 165,303 | 185,460 | ||||||||||||||||||
| Cash dividends | (32,539) | (32,548) | ||||||||||||||||||
| Balance, end of period | 3,195,872 | 3,339,660 | ||||||||||||||||||
Total Shareholders’ Equity | $ | 5,037,287 | $ | 5,139,884 | ||||||||||||||||
MGIC Investment Corporation and Subsidiaries | |||||||||||||||||
Consolidated Statements of Cash Flows (Unaudited) | |||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| (In thousands) | 2026 | 2025 | |||||||||||||||
| Cash flows from operating activities: | |||||||||||||||||
| Net income | $ | 165,303 | $ | 185,460 | |||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||
| Depreciation and amortization | (84) | 2,694 | |||||||||||||||
| Deferred tax expense (benefit) | 7,367 | 9,932 | |||||||||||||||
| Equity compensation | 6,431 | 8,087 | |||||||||||||||
| Net (gains) losses on investments and other financial instruments | 169 | (741) | |||||||||||||||
| Change in certain assets and liabilities: | |||||||||||||||||
| Accrued investment income | 753 | 2,296 | |||||||||||||||
| Reinsurance recoverable on loss reserves | (8,129) | (4,583) | |||||||||||||||
| Reinsurance recoverable on paid losses | 489 | 2,350 | |||||||||||||||
| Premiums receivable | (9,959) | 1,263 | |||||||||||||||
| Deferred insurance policy acquisition costs | 422 | 580 | |||||||||||||||
| Loss reserves | 24,236 | 2,371 | |||||||||||||||
| Unearned premiums | (420) | (8,373) | |||||||||||||||
| Current income taxes | (80,619) | 61,087 | |||||||||||||||
| Other, net | (29,057) | (38,769) | (1) | ||||||||||||||
| Net cash provided by (used in) operating activities | 76,902 | 223,654 | |||||||||||||||
| Cash flows from investing activities: | |||||||||||||||||
| Purchases of investments | (430,297) | (455,780) | |||||||||||||||
| Proceeds from sales of investments | 1,040 | 20,737 | |||||||||||||||
| Proceeds from maturity of fixed income securities | 476,227 | 467,543 | |||||||||||||||
| Additions to property and equipment | (184) | (125) | |||||||||||||||
| Net cash provided by (used in) investing activities | 46,786 | 32,375 | |||||||||||||||
| Cash flows from financing activities: | |||||||||||||||||
| Repurchase of common stock | (192,368) | (225,176) | |||||||||||||||
| Dividends paid | (35,184) | (33,919) | |||||||||||||||
| Payment of withholding taxes related to share-based compensation net share settlement | (22,155) | (18,868) | |||||||||||||||
| Net cash provided by (used in) financing activities | (249,707) | (277,963) | |||||||||||||||
| Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents | (126,019) | (21,934) | |||||||||||||||
| Cash and cash equivalents and restricted cash and cash equivalents at beginning of period | 375,514 | 234,627 | |||||||||||||||
| Cash and cash equivalents and restricted cash and cash equivalents at end of period | $ | 249,495 | $ | 212,693 | |||||||||||||
Long-Term Debt Obligation, Carrying Value | |||||||||||||||||
| Table | 3.1 | ||||||||||||||||
| (In thousands) | March 31, 2026 | December 31, 2025 | |||||||||||||||
5.25% Notes, due August 2028 (par value: $650 million) | $ | 646,506 | $ | 646,138 | |||||||||||||
Earnings Per Share | |||||||||||||||||
| Table | 4.1 | ||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
($ in thousands, except per share data) | 2026 | 2025 | |||||||||||||||
Net income - basic and diluted | $ | 165,303 | $ | 185,460 | |||||||||||||
Basic weighted average common shares outstanding | 216,135 | 244,147 | |||||||||||||||
Dilutive effect of unvested RSUs | 2,051 | 2,343 | |||||||||||||||
Diluted weighted average common shares outstanding | 218,186 | 246,490 | |||||||||||||||
Earnings per share: | |||||||||||||||||
Basic earnings per share | $ | 0.76 | $ | 0.76 | |||||||||||||
| Diluted earnings per share | $ | 0.76 | $ | 0.75 | |||||||||||||
Details of Fixed Income Securities by Category as of March 31, 2026 | |||||||||||||||||||||||||||||
| Table | 5.1a | ||||||||||||||||||||||||||||
| (In thousands) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized (Losses) | Fair Value | |||||||||||||||||||||||||
| U.S. Treasury securities and obligations of U.S. government corporations and agencies | $ | 236,034 | $ | 316 | $ | (2,720) | $ | 233,630 | |||||||||||||||||||||
| Obligations of U.S. states and political subdivisions | 1,902,497 | 8,232 | (138,321) | 1,772,408 | |||||||||||||||||||||||||
| Corporate debt securities | 2,727,634 | 19,830 | (67,327) | 2,680,137 | |||||||||||||||||||||||||
| ABS | 263,392 | 1,367 | (2,118) | 262,641 | |||||||||||||||||||||||||
| RMBS | 361,981 | 5,212 | (16,483) | 350,710 | |||||||||||||||||||||||||
| CMBS | 261,115 | 919 | (3,117) | 258,917 | |||||||||||||||||||||||||
| CLOs | 131,422 | 8 | (209) | 131,221 | |||||||||||||||||||||||||
| Foreign government debt | 4,488 | — | (429) | 4,059 | |||||||||||||||||||||||||
| Commercial paper | 9,398 | — | — | 9,398 | |||||||||||||||||||||||||
Total fixed income securities | $ | 5,897,961 | $ | 35,884 | $ | (230,724) | $ | 5,703,121 | |||||||||||||||||||||
Fixed Income Securities Maturity Schedule | |||||||||||||||||
| Table | 5.2 | ||||||||||||||||
| March 31, 2026 | |||||||||||||||||
| (In thousands) | Amortized cost | Fair Value | |||||||||||||||
| Due in one year or less | $ | 650,211 | $ | 649,526 | |||||||||||||
| Due after one year through five years | 1,697,951 | 1,662,497 | |||||||||||||||
| Due after five years through ten years | 1,626,253 | 1,565,298 | |||||||||||||||
| Due after ten years | 905,636 | 822,311 | |||||||||||||||
| 4,880,051 | 4,699,632 | ||||||||||||||||
| ABS | 263,392 | 262,641 | |||||||||||||||
| RMBS | 361,981 | 350,710 | |||||||||||||||
| CMBS | 261,115 | 258,917 | |||||||||||||||
| CLOs | 131,422 | 131,221 | |||||||||||||||
| Total | $ | 5,897,961 | $ | 5,703,121 | |||||||||||||
Details of Equity Security Investments as of March 31, 2026 | |||||||||||||||||||||||||||||
| Table | 5.3a | ||||||||||||||||||||||||||||
| (In thousands) | Cost | Fair Value Gains | Fair Value Losses | Fair Value | |||||||||||||||||||||||||
| Equity securities | $ | 16,323 | $ | 29 | $ | (1,161) | $ | 15,191 | |||||||||||||||||||||
Details of Equity Security Investments as of December 31, 2025 | |||||||||||||||||||||||||||||
| Table | 5.3b | ||||||||||||||||||||||||||||
| (In thousands) | Cost | Fair Value Gains | Fair Value Losses | Fair Value | |||||||||||||||||||||||||
| Equity securities | $ | 16,286 | $ | 42 | $ | (1,006) | $ | 15,322 | |||||||||||||||||||||
Details of Net Gains (Losses) on Investments and Other Financial Instruments | ||||||||||||||
| Table | 5.4 | Three Months Ended March 31, | ||||||||||||
| (in thousands) | 2026 | 2025 | ||||||||||||
Fixed income securities: | ||||||||||||||
| Gains on sales | $ | 210 | $ | 349 | ||||||||||
| Losses on sales | (10) | (29) | ||||||||||||
Equity securities gains (losses): | ||||||||||||||
Changes in fair value | (168) | 120 | ||||||||||||
Change in embedded derivative on Home Re Transactions(1) | (201) | 301 | ||||||||||||
| Net gains (losses) on investments and other financial instruments | $ | (169) | $ | 741 | ||||||||||
| Proceeds from sales of fixed income securities | $ | 1,005 | $ | 20,737 | ||||||||||
Assets Carried at Fair Value by Hierarchy Level as of March 31, 2026 | |||||||||||||||||||||||
| Table | 6.1a | ||||||||||||||||||||||
| (In thousands) | Total Fair Value | Quoted Prices in Active Markets for Identical Assets (Level 1) | Significant Other Observable Inputs (Level 2) | ||||||||||||||||||||
| U.S. Treasury securities and obligations of U.S. government corporations and agencies | $ | 233,630 | $ | 198,760 | $ | 34,870 | |||||||||||||||||
| Obligations of U.S. states and political subdivisions | 1,772,408 | — | 1,772,408 | ||||||||||||||||||||
| Corporate debt securities | 2,680,137 | — | 2,680,137 | ||||||||||||||||||||
| ABS | 262,641 | — | 262,641 | ||||||||||||||||||||
| RMBS | 350,710 | — | 350,710 | ||||||||||||||||||||
| CMBS | 258,917 | — | 258,917 | ||||||||||||||||||||
| CLOs | 131,221 | — | 131,221 | ||||||||||||||||||||
| Foreign government debt | 4,059 | — | 4,059 | ||||||||||||||||||||
| Commercial paper | 9,398 | — | 9,398 | ||||||||||||||||||||
| Total fixed income securities | 5,703,121 | 198,760 | 5,504,361 | ||||||||||||||||||||
| Equity securities | 15,191 | 15,191 | — | ||||||||||||||||||||
Cash equivalents (1) | 245,491 | 224,114 | 21,377 | ||||||||||||||||||||
| Total | $ | 5,963,803 | $ | 438,065 | $ | 5,525,738 | |||||||||||||||||
| Reinsurance | |||||||||||||||||
| Table | 7.1 | ||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| (In thousands) | 2026 | 2025 | |||||||||||||||
| Premiums earned: | |||||||||||||||||
| Direct | $ | 286,927 | $ | 284,821 | |||||||||||||
| Assumed | 3,980 | 3,561 | |||||||||||||||
Ceded: | |||||||||||||||||
Ceded - quota share reinsurance (1) | (37,769) | (29,943) | |||||||||||||||
| Ceded - excess-of-loss reinsurance | (17,775) | (14,720) | |||||||||||||||
| Total ceded | (55,544) | (44,663) | |||||||||||||||
| Net premiums earned | $ | 235,363 | $ | 243,719 | |||||||||||||
| Losses incurred: | |||||||||||||||||
| Direct | $ | 45,270 | $ | 16,017 | |||||||||||||
| Assumed | (2) | 5 | |||||||||||||||
| Ceded - quota share reinsurance | (12,026) | (6,431) | |||||||||||||||
| Losses incurred, net | $ | 33,242 | $ | 9,591 | |||||||||||||
| Other Reinsurance Impacts: | |||||||||||||||||
Profit commission on quota share reinsurance (1) | $ | 29,103 | $ | 28,695 | |||||||||||||
| Ceding commission on quota share reinsurance | 13,374 | 11,727 | |||||||||||||||
| Quota Share Reinsurance | ||||||||||||||
| Table | 7.3 | |||||||||||||
| Quota Share Contract | Covered Policy Years | Optional Termination Date (1) | Optional Quota Share % Reduction Date (2) | Optional Reduced Quota Share % | ||||||||||
2020 QSR and 2021 QSR | 2021 | December 31, 2027 | January 1, 2028 | 12.3% or 10% | ||||||||||
2021 QSR and 2022 QSR | 2021 | December 31, 2027 | January 1, 2028 | 9.4% or 7% | ||||||||||
| 2021 QSR and 2022 QSR | 2022 | June 30, 2028 | July 1, 2028 | 11.5% or 9.2% | ||||||||||
| 2022 QSR and 2023 QSR | 2022 | June 30, 2028 | July 1, 2028 | 12.1% or 9.7% | ||||||||||
| 2022 QSR and 2023 QSR | 2023 | June 30, 2026 | July 1, 2026 | 12.5% or 10% | ||||||||||
| 2023 QSR | 2023 | June 30, 2026 | July 1, 2026 | 8% or 7% | ||||||||||
2024 QSR | 2024 | December 31, 2027 | December 31, 2027 | 23% or 15% | ||||||||||
2025 QSR | 2025 | December 31, 2027 | December 31, 2027 | 30% or 20% | ||||||||||
2026 QSR | 2026 | December 31, 2028 | December 31, 2028 | 30% or 20% | ||||||||||
Excess of Loss Reinsurance | ||||||||||||||
| Table 7.4a | ||||||||||||||
| Issue Date | Policy In Force Dates | Optional Call Date (1) | Legal Maturity | |||||||||||
2026 Traditional XOL | January 1, 2026 | January 1, 2026 - December 31, 2026 | January 1, 2032 | 10 years | ||||||||||
2025 Traditional XOL | June 1, 2025 | January 1, 2025 - December 31, 2025 | January 1, 2031 | 10 years | ||||||||||
2024 Traditional XOL | April 1, 2024 | January 1, 2024 - December 31, 2024 | January 1, 2030 | 10 years | ||||||||||
| 2023 Traditional XOL | April 1, 2023 | January 1, 2023 - December 29, 2023 | January 1, 2031 | 10 years | ||||||||||
| 2022 Traditional XOL | April 1, 2022 | January 1, 2022 - December 30, 2022 | January 1, 2030 | 10 years | ||||||||||
2021 Traditional XOL | December 1, 2025 | January 1, 2021 - December 31, 2021 | January 1, 2031 | 10 years | ||||||||||
2020 Traditional XOL | March 1, 2025 | January 1, 2020 - December 31, 2020 | April 1, 2030 | 10 years | ||||||||||
Home Re 2026-1, Ltd. | January 29, 2026 | January 1, 2022 - March 31, 2025 | January 25, 2031 | 10 years | ||||||||||
| Home Re 2023-1, Ltd. | October 23, 2023 | June 1, 2022 - August 31, 2023 | October 25, 2028 | 10 years | ||||||||||
| Home Re 2022-1, Ltd. | April 26, 2022 | May 29, 2021 - December 31, 2021 | April 25, 2028 | 12.5 years | ||||||||||
| Home Re 2021-2, Ltd. | August 3, 2021 | January 1, 2021 - May 28, 2021 | July 25, 2028 | 12.5 years | ||||||||||
Table 7.4b | Remaining First Layer Retention | ||||||||||
| ($ in thousands) | Initial First Layer Retention | March 31, 2026 | December 31, 2025 | ||||||||
2025 Traditional XOL | $ | 95,966 | $ | 95,966 | $ | 95,966 | |||||
| 2024 Traditional XOL | 125,016 | 123,596 | 124,458 | ||||||||
| 2023 Traditional XOL | 70,578 | 68,299 | 69,060 | ||||||||
| 2022 Traditional XOL | 82,523 | 76,952 | 78,023 | ||||||||
2021 Traditional XOL | 142,291 | 142,291 | 142,291 | ||||||||
2020 Traditional XOL | 68,343 | 68,288 | 68,288 | ||||||||
Home Re 2026-1, Ltd. | 231,769 | 231,750 | N/A | ||||||||
Home Re 2023-1, Ltd. | 272,961 | 263,855 | 266,371 | ||||||||
| Home Re 2022-1, Ltd. | 325,589 | 317,741 | 318,906 | ||||||||
| Home Re 2021-2, Ltd. | 190,159 | 186,537 | 187,030 | ||||||||
Table 7.4c | Remaining Excess of Loss Reinsurance Coverage (1) | ||||||||||||||||
| ($ in thousands) | Initial Excess of Loss Reinsurance Coverage (1) | Initial Funding Percentage (2) | Funding Percentage at 3/31/2026 (2) | March 31, 2026 | December 31, 2025 | ||||||||||||
2025 Traditional XOL | $ | 151,851 | N/A | N/A | $ | 151,851 | $ | 151,851 | |||||||||
| 2024 Traditional XOL | 187,220 | N/A | N/A | 178,796 | 187,220 | ||||||||||||
| 2023 Traditional XOL | 96,942 | N/A | N/A | 59,066 | 64,217 | ||||||||||||
| 2022 Traditional XOL | 142,642 | N/A | N/A | 97,362 | 100,274 | ||||||||||||
2021 Traditional XOL | 250,000 | N/A | N/A | 250,000 | 250,000 | ||||||||||||
2020 Traditional XOL | 250,592 | N/A | N/A | 250,592 | 250,592 | ||||||||||||
Home Re 2026-1, Ltd. | 323,504 | 100 | % | 100 | % | 322,204 | N/A | ||||||||||
| Home Re 2023-1, Ltd. | 330,277 | 97 | % | 95 | % | 214,444 | 231,708 | ||||||||||
| Home Re 2022-1, Ltd. | 473,575 | 100 | % | 100 | % | 188,763 | 207,641 | ||||||||||
Home Re 2021-2, Ltd. | 398,429 | 100 | % | 100 | % | 68,267 | 84,376 | ||||||||||
| Home Re total assets | |||||||||||||||||
| Table | 7.5 | ||||||||||||||||
| (In thousands) | Total VIE Assets | ||||||||||||||||
| Home Re Entity | March 31, 2026 | December 31, 2025 | |||||||||||||||
Home Re 2026-1 Ltd. | $ | 323,504 | N/A | ||||||||||||||
| Home Re 2023-1 Ltd. | 221,144 | 237,900 | |||||||||||||||
| Home Re 2022-1 Ltd. | 196,027 | 214,788 | |||||||||||||||
| Home Re 2021-2 Ltd. | 74,244 | 89,865 | |||||||||||||||
Development of Reserves for Losses and Loss Adjustment Expenses | |||||||||||||||||
| Table | 8.1 | ||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| (In thousands) | 2026 | 2025 | |||||||||||||||
| Reserve at beginning of period | $ | 474,884 | $ | 462,662 | |||||||||||||
| Less reinsurance recoverable | 65,055 | 47,281 | |||||||||||||||
| Net reserve at beginning of period | 409,829 | 415,381 | |||||||||||||||
| Losses incurred: | |||||||||||||||||
| Losses and LAE incurred in respect of delinquency notices received in: | |||||||||||||||||
| Current year | 64,471 | 59,497 | |||||||||||||||
Prior years (1) | (31,229) | (49,906) | |||||||||||||||
| Total losses incurred | 33,242 | 9,591 | |||||||||||||||
| Losses paid: | |||||||||||||||||
| Losses and LAE paid in respect of delinquency notices received in: | |||||||||||||||||
| Current year | 15 | — | |||||||||||||||
| Prior years | 17,120 | 11,803 | |||||||||||||||
| Total losses paid | 17,135 | 11,803 | |||||||||||||||
| Net reserve at end of period | 425,936 | 413,169 | |||||||||||||||
| Plus reinsurance recoverable | 73,184 | 51,864 | |||||||||||||||
| Reserve at end of period | $ | 499,120 | $ | 465,033 | |||||||||||||
Reserve Development on Previously Received Delinquencies | |||||||||||||||||
| Table | 8.2 | ||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| (In thousands) | 2026 | 2025 | |||||||||||||||
| Increase (decrease) in estimated claim rate on primary defaults | $ | (26,965) | $ | (46,497) | |||||||||||||
| Change in estimates related to severity on primary defaults, pool reserves, LAE reserves, reinsurance, and other | (4,264) | (3,409) | |||||||||||||||
Total prior year loss development (1) | $ | (31,229) | $ | (49,906) | |||||||||||||
Components of Other Comprehensive Income (Loss) | |||||||||||||||||
| Table | 9.1 | ||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| (In thousands) | 2026 | 2025 | |||||||||||||||
| Net unrealized investment (losses) gains arising during the period | $ | (42,073) | $ | 65,406 | |||||||||||||
| Total income tax benefit (expense) | 8,835 | (13,735) | |||||||||||||||
Net of tax | (33,238) | 51,671 | |||||||||||||||
| Net changes in benefit plan assets and obligations | 190 | 58 | |||||||||||||||
| Total income tax benefit (expense) | (40) | (12) | |||||||||||||||
Net of tax | 150 | 46 | |||||||||||||||
| Total other comprehensive income (loss) | $ | (41,883) | 65,464 | ||||||||||||||
| Total income tax benefit (expense) | 8,795 | (13,747) | |||||||||||||||
| Total other comprehensive income (loss), net of tax | $ | (33,088) | $ | 51,717 | |||||||||||||
| Reclassifications from AOCI | |||||||||||||||||
| Table | 9.2 | ||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| (In thousands) | 2026 | 2025 | |||||||||||||||
Reclassification adjustment for net realized (losses) gains (1) | $ | (98) | $ | (5,981) | |||||||||||||
| Income tax benefit (expense) | 21 | 1,256 | |||||||||||||||
Net of tax | (77) | (4,725) | |||||||||||||||
Reclassification adjustment related to benefit plan assets and obligations (2) | (190) | (58) | |||||||||||||||
| Income tax benefit (expense) | 40 | 12 | |||||||||||||||
Net of tax | (150) | (46) | |||||||||||||||
| Total reclassifications | (288) | (6,039) | |||||||||||||||
| Income tax benefit (expense) | 61 | 1,268 | |||||||||||||||
| Total reclassifications, net of tax | $ | (227) | $ | (4,771) | |||||||||||||
| Rollforward of AOCI | |||||||||||||||||||||||
| Table | 9.3 | ||||||||||||||||||||||
| Three Months Ended March 31, 2026 | |||||||||||||||||||||||
| (In thousands) | Net unrealized gains and (losses) on available-for-sale securities | Net benefit plan assets and (obligations) recognized in shareholders' equity | Total accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Balance at December 31, 2025, net of tax | $ | (120,686) | $ | (13,708) | $ | (134,394) | |||||||||||||||||
| Other comprehensive income (loss) before reclassifications | (33,315) | — | (33,315) | ||||||||||||||||||||
| Less: Amounts reclassified from AOCI | (77) | (150) | (227) | ||||||||||||||||||||
| Balance, March 31, 2026, net of tax | $ | (153,924) | $ | (13,558) | $ | (167,482) | |||||||||||||||||
Significant Segment Expenses | |||||||||||||||||
| Table | 14.1 | ||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
(In thousands) | 2026 | 2025 | |||||||||||||||
Other underwriting and operating expenses net: | |||||||||||||||||
Employee costs | $ | 36,432 | $ | 36,960 | |||||||||||||
Outside services (1) | 6,420 | 7,811 | |||||||||||||||
Premium taxes (2) | 5,503 | 5,410 | |||||||||||||||
Depreciation expense | 691 | 943 | |||||||||||||||
All other underwriting and operating (3) | (2,162) | 282 | |||||||||||||||
Total other underwriting and operating expenses net | $ | 46,884 | $ | 51,406 | |||||||||||||
Non-GAAP Reconciliations | ||||||||||||||||||||||||||||||||||||||
Reconciliation of Income before tax / Net income to Adjusted pre-tax operating income / Adjusted net operating income | ||||||||||||||||||||||||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||||||||||||||||||||||||||
| 2026 | 2025 | |||||||||||||||||||||||||||||||||||||
| (In thousands, except per share amounts) | Pre-tax | Tax effect | Net (after-tax) | Pre-tax | Tax effect | Net (after-tax) | ||||||||||||||||||||||||||||||||
| Income before tax / Net income | $ | 206,828 | 41,525 | $ | 165,303 | $ | 234,681 | 49,221 | $ | 185,460 | ||||||||||||||||||||||||||||
| Adjustments: | ||||||||||||||||||||||||||||||||||||||
| Net realized investment (gains) losses | (200) | (42) | (158) | (319) | (67) | (252) | ||||||||||||||||||||||||||||||||
| Adjusted pre-tax operating income / Adjusted net operating income | $ | 206,628 | $ | 41,483 | $ | 165,145 | $ | 234,362 | $ | 49,154 | $ | 185,208 | ||||||||||||||||||||||||||
| Reconciliation of Net income per diluted share to Adjusted net operating income per diluted share | ||||||||||||||||||||||||||||||||||||||
Weighted average shares - diluted | 218,186 | 246,490 | ||||||||||||||||||||||||||||||||||||
| Net income per diluted share | $ | 0.76 | $ | 0.75 | ||||||||||||||||||||||||||||||||||
| Net realized investment (gains) losses | 0.00 | 0.00 | ||||||||||||||||||||||||||||||||||||
| Adjusted net operating income per diluted share | $ | 0.76 | $ | 0.75 | ||||||||||||||||||||||||||||||||||
Primary NIW by Credit Score | |||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
(% of primary NIW) | 2026 | 2025 | |||||||||||||||
| 760 and greater | 50.4 | % | 51.0 | % | |||||||||||||
| 740 - 759 | 17.9 | % | 17.3 | % | |||||||||||||
| 720 - 739 | 13.1 | % | 13.3 | % | |||||||||||||
| 700 - 719 | 8.6 | % | 9.4 | % | |||||||||||||
| 680 - 699 | 5.0 | % | 5.3 | % | |||||||||||||
| 660 - 679 | 2.9 | % | 2.7 | % | |||||||||||||
| 640 - 659 | 1.4 | % | 0.7 | % | |||||||||||||
| 639 and less | 0.7 | % | 0.3 | % | |||||||||||||
Total | 100 | % | 100 | % | |||||||||||||
Primary NIW by Loan-to-Value | |||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| (% of primary NIW) | 2026 | 2025 | |||||||||||||||
| 95.01% and above | 13.9 | % | 12.9 | % | |||||||||||||
| 90.01% to 95.00% | 44.7 | % | 45.5 | % | |||||||||||||
| 85.01% to 90.00% | 30.3 | % | 29.9 | % | |||||||||||||
| 80.01% to 85.00% | 11.1 | % | 11.7 | % | |||||||||||||
Total | 100 | % | 100 | % | |||||||||||||
Primary NIW by Debt-to-Income Ratio | ||||||||||||||
| Three Months Ended March 31, | ||||||||||||||
| (% of primary NIW) | 2026 | 2025 | ||||||||||||
| 45.01% and above | 25.4 | % | 31.1 | % | ||||||||||
| 38.01% to 45.00% | 29.0 | % | 30.5 | % | ||||||||||
| 38.00% and below | 45.6 | % | 38.4 | % | ||||||||||
Total | 100 | % | 100 | % | ||||||||||
Primary NIW by Policy Payment Type | ||||||||||||||
| Three Months Ended March 31, | ||||||||||||||
| (% of primary NIW) | 2026 | 2025 | ||||||||||||
| Monthly premiums | 96.3 | % | 97.3 | % | ||||||||||
| Single premiums | 3.7 | % | 2.7 | % | ||||||||||
Total | 100 | % | 100 | % | ||||||||||
Primary NIW by Type of Mortgage | ||||||||||||||
| Three Months Ended March 31, | ||||||||||||||
| (% of primary NIW) | 2026 | 2025 | ||||||||||||
| Purchases | 79.4 | % | 94.4 | % | ||||||||||
| Refinances | 20.6 | % | 5.6 | % | ||||||||||
Total | 100 | % | 100 | % | ||||||||||
Primary NIW by Number of Attributes Discussed Above | |||||||||||
| Three Months Ended March 31, | |||||||||||
| (% of primary NIW) | 2026 | 2025 | |||||||||
| One | 35.2 | % | 38.2 | % | |||||||
| Two or more | 4.5 | % | 4.7 | % | |||||||
Primary IIF and RIF | |||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| (In billions) | 2026 | 2025 | |||||||||||||||
| NIW | $ | 14.4 | $ | 10.2 | |||||||||||||
Cancellations, principal payments, and other reductions | (14.8) | (11.8) | |||||||||||||||
| Increase (decrease) in primary IIF | $ | (0.4) | $ | (1.6) | |||||||||||||
| Direct primary IIF as of March 31, | $ | 302.7 | $ | 293.8 | |||||||||||||
| Direct primary RIF as of March 31, | $ | 81.2 | $ | 78.5 | |||||||||||||
Primary IIF and RIF by Policy Year | ||||||||||||||||||||||||||
As of March 31, | ||||||||||||||||||||||||||
($ in millions) | 2026 | 2025 | ||||||||||||||||||||||||
Policy year | Insurance in force | Risk in Force | Insurance in Force | Risk in Force | ||||||||||||||||||||||
| 2004 and prior | $ | 969 | $ | 275 | $ | 1,123 | $ | 318 | ||||||||||||||||||
| 2005 - 2008 | 7,345 | 1,964 | 8,504 | 2,271 | ||||||||||||||||||||||
2009 - 2019 | 19,661 | 5,208 | 25,415 | 6,731 | ||||||||||||||||||||||
2020 | 27,382 | 7,581 | 35,854 | 9,825 | ||||||||||||||||||||||
2021 | 53,823 | 15,094 | 66,363 | 18,186 | ||||||||||||||||||||||
2022 | 49,999 | 13,558 | 57,538 | 15,427 | ||||||||||||||||||||||
2023 | 31,126 | 8,122 | 37,921 | 9,844 | ||||||||||||||||||||||
2024 | 44,630 | 11,673 | 52,342 | 13,628 | ||||||||||||||||||||||
2025 | 55,108 | 14,398 | 8,717 | 2,256 | ||||||||||||||||||||||
2026 | 12,636 | 3,287 | — | — | ||||||||||||||||||||||
| Total | $ | 302,679 | $ | 81,160 | $ | 293,777 | $ | 78,486 | ||||||||||||||||||
Portfolio Statistics by Policy Year | ||||||||||||||
| Weighted Avg. Interest Rate | Delinquency Rate % | Cede Rate % (1) | % of Original Remaining IIF | |||||||||||
| Policy Year | ||||||||||||||
| 2004 and prior | 7.3 | % | 12.1 | % | — | % | N/M | |||||||
| 2005-2008 | 7.0 | % | 9.3 | % | — | % | 3.0 | % | ||||||
| 2009-2019 | 4.3 | % | 4.1 | % | — | % | 5.0 | % | ||||||
| 2020 | 3.2 | % | 1.8 | % | 5.0 | % | 24.0 | % | ||||||
| 2021 | 3.1 | % | 2.2 | % | 27.5 | % | 45.7 | % | ||||||
| 2022 | 4.9 | % | 2.5 | % | 31.0 | % | 67.4 | % | ||||||
| 2023 | 6.5 | % | 2.2 | % | 26.9 | % | 67.6 | % | ||||||
| 2024 | 6.6 | % | 1.5 | % | 30.7 | % | 79.4 | % | ||||||
| 2025 | 6.5 | % | 0.5 | % | 39.3 | % | 91.1 | % | ||||||
| 2026 | 6.0 | % | 0.0 | % | 39.0 | % | 99.6 | % | ||||||
| Three Months Ended March 31, | ||||||||||||||||||||
(in thousands, except per share data and effective tax rate) | 2026 | 2025 | Change | |||||||||||||||||
| Revenues | ||||||||||||||||||||
| Net premiums earned | $ | 235,363 | $ | 243,719 | (3) | % | ||||||||||||||
| Net investment income | 61,742 | 61,443 | 0 | % | ||||||||||||||||
| Net gains (losses) on investments and other financial instruments | (169) | 741 | N/M | |||||||||||||||||
| Other revenue | 141 | 331 | (57) | % | ||||||||||||||||
| Total revenues | 297,077 | 306,234 | (3) | % | ||||||||||||||||
| Losses and expenses | ||||||||||||||||||||
| Losses incurred, net | 33,242 | 9,591 | 247 | % | ||||||||||||||||
| Underwriting and other expenses, net | 48,108 | 53,063 | (9) | % | ||||||||||||||||
| Interest expense | 8,899 | 8,899 | 0 | % | ||||||||||||||||
| Total losses and expenses | 90,249 | 71,553 | 26 | % | ||||||||||||||||
Income before tax | 206,828 | 234,681 | (12) | % | ||||||||||||||||
| Provision for income taxes | 41,525 | 49,221 | (16) | % | ||||||||||||||||
Net income | $ | 165,303 | $ | 185,460 | (11) | % | ||||||||||||||
| Net income per diluted share | $ | 0.76 | $ | 0.75 | 1 | % | ||||||||||||||
| Effective tax rate | 20.1 | % | 21.0 | % | (0.9) bps | |||||||||||||||
Non-GAAP Financial Measures (1) | ||||||||||||||||||||
| Adjusted pre-tax operating income | $ | 206,628 | $ | 234,362 | (12) | % | ||||||||||||||
| Adjusted net operating income | 165,145 | 185,208 | (11) | % | ||||||||||||||||
| Adjusted net operating income per diluted share | $ | 0.76 | $ | 0.75 | 1 | % | ||||||||||||||
| Premium Yield | |||||||||||
Three Months Ended March 31, | |||||||||||
| (in basis points) | 2026 | 2025 | |||||||||
In force portfolio yield (1) | 38.0 | 38.4 | |||||||||
| Premium refunds | (0.3) | 0.0 | |||||||||
| Accelerated earnings on single premium policies | 0.2 | 0.2 | |||||||||
| Total direct premium yield | 37.9 | 38.6 | |||||||||
Ceded premiums earned, net of profit commission and assumed premiums (2) | (6.8) | (5.6) | |||||||||
| Net premium yield | 31.1 | 33.0 | |||||||||
Three Months Ended March 31, | ||||||||||||||
($ in thousands) | 2026 | 2025 | ||||||||||||
| Ceded premiums written and earned, net of profit commission | $ | 37,769 | $ | 29,943 | ||||||||||
| % of direct premiums written | 13 | % | 11 | % | ||||||||||
| % of direct premiums earned | 13 | % | 11 | % | ||||||||||
| Profit commission | $ | 29,103 | $ | 28,695 | ||||||||||
| Ceding commissions | $ | 13,374 | $ | 11,727 | ||||||||||
| Ceded losses incurred | $ | 12,026 | $ | 6,431 | ||||||||||
As of March 31, | ||||||||||||||
| Ceded RIF ($ in millions) | 2026 | 2025 | ||||||||||||
| 2021 QSR | 3,612 | 4,310 | ||||||||||||
| 2022 QSR | 3,479 | 4,167 | ||||||||||||
| 2023 QSR | 1,712 | 2,082 | ||||||||||||
2024 QSR | 2,987 | 3,519 | ||||||||||||
2025 QSR | 4,863 | 584 | ||||||||||||
2026 QSR | 1,263 | — | ||||||||||||
| Credit Union QSR | 3,287 | 2,877 | ||||||||||||
| Total ceded RIF | $ | 21,203 | $ | 17,539 | ||||||||||
Quota Share Reinsurance | ||||||||||||||
| Three Months Ended March 31, | ||||||||||||||
| 2026 | 2025 | |||||||||||||
| NIW subject to QSR Transactions | 86.4 | % | 86.8 | % | ||||||||||
| New Risk Written subject to QSR Transactions | 92.5 | % | 93.0 | % | ||||||||||
| IIF subject to QSR Transactions | 74.9 | % | 69.5 | % | ||||||||||
| RIF subject to QSR Transactions | 78.2 | % | 72.7 | % | ||||||||||
| ($ In thousands) | Initial Attachment % (1) | Initial Detachment % (2) | Current Attachment % (1) | Current Detachment % (2) | PMIERs Required Asset Credit | |||||||||||||||
| 2025 Traditional XOL | 2.53% | 6.53% | 2.63% | 6.79% | $ | 146,038 | ||||||||||||||
| 2024 Traditional XOL | 2.67% | 6.67% | 3.16% | 7.73% | 171,905 | |||||||||||||||
| 2023 Traditional XOL | 2.91% | 6.91% | 3.94% | 7.35% | 56,772 | |||||||||||||||
| 2022 Traditional XOL | 2.60% | 7.10% | 3.32% | 7.51% | 93,651 | |||||||||||||||
2021 Traditional XOL | 1.25% | 3.48% | 1.33% | 3.67% | 240,346 | |||||||||||||||
2020 Traditional XOL | 0.75% | 3.50% | 0.99% | 4.63% | 240,883 | |||||||||||||||
Home Re 2026-1 | 2.40% | 5.75% | 2.57% | 6.15% | 306,094 | |||||||||||||||
Home Re 2023-1 | 3.00% | 6.75% | 3.91% | 7.25% | 194,689 | |||||||||||||||
| Home Re 2022-1 | 2.75% | 6.75% | 4.70% | 7.50% | 149,779 | |||||||||||||||
| Home Re 2021-2 | 2.10% | 6.50% | 5.31% | 7.25% | 47,182 | |||||||||||||||
Composition of Losses Incurred | |||||||||||
| Three Months Ended March 31, | |||||||||||
($ in thousands) | 2026 | 2025 | |||||||||
| Current year / New notices | $ | 64,471 | $ | 59,497 | |||||||
| Prior year reserve development | (31,229) | (49,906) | |||||||||
Losses incurred, net | $ | 33,242 | $ | 9,591 | |||||||
Loss Ratio | 14.1 | % | 3.9 | % | |||||||
Delinquency Inventory Rollforward | |||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| 2026 | 2025 | ||||||||||||||||
| Delinquency inventory at beginning of period | 27,072 | 26,791 | |||||||||||||||
| New notices | 13,791 | 12,965 | |||||||||||||||
| Cures | (13,393) | (13,981) | |||||||||||||||
| Paid claims | (457) | (312) | |||||||||||||||
| Rescissions and denials | (7) | (25) | |||||||||||||||
| Delinquency inventory at end of period | 27,006 | 25,438 | |||||||||||||||
New Notices and Delinquency Inventory During the Period | |||||||||||
March 31, 2026 | |||||||||||
| Policy Year | New Delinquency Notices Received in the Three Months Ended | Delinquency Inventory | Avg. Number of Missed Payments of Delinquency Inventory | ||||||||
| 2004 and prior | 605 | 1,482 | 14 | ||||||||
| 2005-2008 | 2,011 | 4,762 | 14 | ||||||||
2009-2017 | 959 | 2,080 | 8 | ||||||||
| 2018 | 617 | 1,323 | 7 | ||||||||
| 2019 | 699 | 1,312 | 7 | ||||||||
| 2020 | 1,214 | 2,186 | 6 | ||||||||
| 2021 | 2,473 | 4,572 | 6 | ||||||||
| 2022 | 2,113 | 4,201 | 6 | ||||||||
| 2023 | 1,102 | 2,158 | 6 | ||||||||
| 2024 | 1,242 | 2,103 | 5 | ||||||||
| 2025 | 756 | 827 | 3 | ||||||||
| 2026 | — | — | — | ||||||||
| Total | 13,791 | 27,006 | 8 | ||||||||
Claim rate on new notices (1) | 7.5 | % | |||||||||
March 31, 2025 | |||||||||||
| Policy Year | New Delinquency Notices Received in the Three Months Ended | Delinquency Inventory | Avg. Number of Missed Payments of Delinquency Inventory | ||||||||
| 2004 and prior | 695 | 1,692 | 15 | ||||||||
| 2005-2008 | 2,138 | 5,429 | 15 | ||||||||
2009-2017 | 1,261 | 2,674 | 9 | ||||||||
| 2018 | 669 | 1,483 | 8 | ||||||||
| 2019 | 730 | 1,378 | 7 | ||||||||
| 2020 | 1,226 | 2,213 | 6 | ||||||||
| 2021 | 2,474 | 4,379 | 6 | ||||||||
| 2022 | 2,051 | 3,804 | 6 | ||||||||
| 2023 | 991 | 1,572 | 5 | ||||||||
| 2024 | 728 | 812 | 4 | ||||||||
| 2025 | 2 | 2 | 2 | ||||||||
| Total | 12,965 | 25,438 | 9 | ||||||||
Claim rate on new notices (1) | 7.5 | % | |||||||||
(1) Claim rate at the time new delinquency notices are received. | |||||||||||
Claims Severity Trend | ||||||||||||||||||||||||||
| Period | Average exposure on claim paid | Average claim paid | % Paid to exposure | Average number of missed payments at claim received date | ||||||||||||||||||||||
Q1 2026 | $ | 56,479 | $ | 42,655 | 75.5 | % | 27 | |||||||||||||||||||
Q4 2025 | 59,228 | 46,061 | 77.8 | % | 29 | |||||||||||||||||||||
Q3 2025 | 55,846 | 39,689 | 71.1 | % | 30 | |||||||||||||||||||||
Q2 2025 | 50,411 | 36,536 | 72.5 | % | 30 | |||||||||||||||||||||
Q1 2025 | 55,297 | 38,826 | 70.2 | % | 34 | |||||||||||||||||||||
Delinquency Inventory - Number of Payments Delinquent | |||||||||||||||||||||||
March 31, 2026 | December 31, 2025 | March 31, 2025 | |||||||||||||||||||||
| 3 payments or less | 13,376 | 14,121 | 12,319 | ||||||||||||||||||||
| 4-11 payments | 9,364 | 8,747 | 8,788 | ||||||||||||||||||||
12 payments or more (1) | 4,266 | 4,204 | 4,331 | ||||||||||||||||||||
| Total | 27,006 | 27,072 | 25,438 | ||||||||||||||||||||
| 3 payments or less | 49 | % | 52 | % | 48 | % | |||||||||||||||||
| 4-11 payments | 35 | % | 32 | % | 35 | % | |||||||||||||||||
| 12 payments or more | 16 | % | 16 | % | 17 | % | |||||||||||||||||
| Total | 100 | % | 100 | % | 100 | % | |||||||||||||||||
Net Losses and LAE Paid | |||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
| (In millions) | 2026 | 2025 | |||||||||||||||
Direct primary (excluding settlements) | $ | 20 | $ | 12 | |||||||||||||
| Reinsurance | (4) | (2) | |||||||||||||||
LAE and other | 1 | 2 | |||||||||||||||
| Net losses and LAE paid | $ | 17 | $ | 12 | |||||||||||||
Loss Reserves | |||||||||||||||||
| March 31, 2026 | December 31, 2025 | March 31, 2025 | |||||||||||||||
Primary (in millions): | |||||||||||||||||
Direct case loss reserves | $ | 435 | $ | 412 | $ | 404 | |||||||||||
| Direct IBNR and LAE reserves | 62 | 60 | 58 | ||||||||||||||
| Total primary direct loss reserves | $ | 497 | $ | 472 | $ | 462 | |||||||||||
Ending delinquent inventory (count based) | 27,006 | 27,072 | 25,438 | ||||||||||||||
| Percentage of loans delinquent (delinquency rate) | 2.44 | % | 2.43 | % | 2.30 | % | |||||||||||
Average total primary loss reserves per delinquency | $ | 18,398 | $ | 17,449 | $ | 18,167 | |||||||||||
Primary claims received inventory included in ending delinquent inventory (count based) | 383 | 398 | 304 | ||||||||||||||
Delinquency Inventory by Jurisdiction | ||||||||||||||||||||
| March 31, 2026 | December 31, 2025 | March 31, 2025 | ||||||||||||||||||
Florida * | 2,357 | 2,291 | 2,338 | |||||||||||||||||
Texas | 2,210 | 2,245 | 2,031 | |||||||||||||||||
| Illinois * | 1,719 | 1,769 | 1,664 | |||||||||||||||||
California | 1,649 | 1,623 | 1,542 | |||||||||||||||||
| Pennsylvania * | 1,511 | 1,522 | 1,390 | |||||||||||||||||
Michigan | 1,340 | 1,301 | 1,171 | |||||||||||||||||
New York * | 1,255 | 1,204 | 1,172 | |||||||||||||||||
Ohio * | 1,193 | 1,276 | 1,173 | |||||||||||||||||
| Georgia | 1,065 | 1,040 | 999 | |||||||||||||||||
| North Carolina | 794 | 766 | 756 | |||||||||||||||||
| All other jurisdictions | 11,913 | 12,035 | 11,202 | |||||||||||||||||
| Total | 27,006 | 27,072 | 25,438 | |||||||||||||||||
Primary Average RIF - Delinquent Loans | ||||||||||||||||||||
| March 31, 2026 | December 31, 2025 | March 31, 2025 | ||||||||||||||||||
Florida | $ | 76,019 | $ | 73,620 | $ | 69,480 | ||||||||||||||
Texas | 69,269 | 68,787 | 65,308 | |||||||||||||||||
| Illinois | 49,295 | 48,443 | 46,242 | |||||||||||||||||
California | 118,622 | 114,904 | 112,612 | |||||||||||||||||
| Pennsylvania | 49,887 | 48,413 | 46,072 | |||||||||||||||||
All other jurisdictions | 61,439 | 59,991 | 57,680 | |||||||||||||||||
| All jurisdictions | $ | 65,424 | $ | 63,760 | $ | 61,323 | ||||||||||||||
Delinquency Inventory by Policy Year | ||||||||||||||||||||
| March 31, 2026 | December 31, 2025 | March 31, 2025 | ||||||||||||||||||
| Policy year: | ||||||||||||||||||||
| 2004 and prior | 1,482 | 1,557 | 1,692 | |||||||||||||||||
| 2005 - 2008 | 4,762 | 4,871 | 5,429 | |||||||||||||||||
2009 - 2017 | 2,080 | 2,264 | 2,674 | |||||||||||||||||
| 2018 | 1,323 | 1,424 | 1,483 | |||||||||||||||||
| 2019 | 1,312 | 1,369 | 1,378 | |||||||||||||||||
| 2020 | 2,186 | 2,268 | 2,213 | |||||||||||||||||
| 2021 | 4,572 | 4,739 | 4,379 | |||||||||||||||||
| 2022 | 4,201 | 4,227 | 3,804 | |||||||||||||||||
| 2023 | 2,158 | 2,044 | 1,572 | |||||||||||||||||
| 2024 | 2,103 | 1,844 | 812 | |||||||||||||||||
| 2025 | 827 | 465 | 2 | |||||||||||||||||
| 2026 | — | — | — | |||||||||||||||||
| Total | 27,006 | 27,072 | 25,438 | |||||||||||||||||
| Three Months Ended March 31, | ||||||||||||||
| 2026 | 2025 | |||||||||||||
| Underwriting expense ratio | 20.5 | % | 22.5 | % | ||||||||||
($ in thousands) | March 31, 2026 | December 31, 2025 | % Change | ||||||||||||||
| Investments | $ | 5,719,421 | $ | 5,807,662 | (2) | % | |||||||||||
| Cash and cash equivalents | 235,090 | 368,989 | (36) | % | |||||||||||||
Reinsurance recoverable on loss reserves (1) | 73,184 | 65,055 | 12 | % | |||||||||||||
Deferred incomes taxes, net | 15,494 | 18,512 | (16) | % | |||||||||||||
| Other assets | 373,560 | 379,268 | (2) | % | |||||||||||||
| Total Assets | $ | 6,416,749 | $ | 6,639,486 | (3) | % | |||||||||||
(1) See "Liabilities and Equity" section below for further discussion. | |||||||||||||||||
Portfolio Duration and Embedded Investment Yield | |||||||||||||||||
| March 31, 2026 | December 31, 2025 | ||||||||||||||||
Effective duration (in years) | 4.2 | 4.2 | |||||||||||||||
Pre-tax yield (1) | 4.0% | 4.0% | |||||||||||||||
After-tax yield (1) | 3.2% | 3.2% | |||||||||||||||
Fixed Income Security Ratings | ||||||||||||||
Security Ratings (1) | March 31, 2026 | December 31, 2025 | ||||||||||||
AAA | 14% | 12% | ||||||||||||
AA | 34% | 36% | ||||||||||||
A | 34% | 34% | ||||||||||||
BBB | 18% | 18% | ||||||||||||
| (in thousands) | March 31, 2026 | December 31, 2025 | % Change | ||||||||||||||
| Loss reserves | $ | 499,120 | $ | 474,884 | 5 | % | |||||||||||
| Unearned premiums | 92,606 | 93,026 | 0 | % | |||||||||||||
| Long-term debt | 646,506 | 646,138 | 0 | % | |||||||||||||
Federal tax credit payable | 16,110 | 135,344 | (88) | % | |||||||||||||
| Other liabilities | 125,120 | 142,543 | (12) | % | |||||||||||||
| Total Liabilities | $ | 1,379,462 | $ | 1,491,935 | (8) | % | |||||||||||
| Common stock | 213,200 | 219,367 | (3) | % | |||||||||||||
| Paid-in capital | 1,795,697 | 1,812,463 | (1) | % | |||||||||||||
| Accumulated other comprehensive income (loss), net of tax | (167,482) | (134,394) | (25) | % | |||||||||||||
| Retained earnings | 3,195,872 | 3,250,115 | (2) | % | |||||||||||||
| Shareholders’ equity | $ | 5,037,287 | $ | 5,147,551 | (2) | % | |||||||||||
Summary of Consolidated Cash Flows | |||||||||||||||||
| Three Months Ended March 31, | |||||||||||||||||
($ in thousands) | 2026 | 2025 | |||||||||||||||
| Total cash provided by (used in): | |||||||||||||||||
| Operating activities | $ | 76,902 | $ | 223,654 | |||||||||||||
| Investing activities | 46,786 | 32,375 | |||||||||||||||
| Financing activities | (249,707) | (277,963) | |||||||||||||||
| Increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents | $ | (126,019) | $ | (21,934) | |||||||||||||
| PMIERs - Reinsurance Credit | ||||||||||||||
| (In millions) | March 31, 2026 | December 31, 2025 | ||||||||||||
| QSR Transactions | $ | 1,455 | $ | 1,402 | ||||||||||
| Home Re Transactions | 697 | 434 | ||||||||||||
| Traditional XOL Transactions | 986 | 966 | ||||||||||||
| Total capital credit for Reinsurance Transactions | $ | 3,138 | $ | 2,802 | ||||||||||
| Risk-to-capital - MGIC | |||||||||||||||||
($ in millions) | March 31, 2026 | December 31, 2025 | |||||||||||||||
RIF - net (1) | $ | 56,524 | $ | 57,598 | |||||||||||||
| Statutory policyholders’ surplus | 1,028 | 887 | |||||||||||||||
| Statutory contingency loss reserve | 4,880 | 4,853 | |||||||||||||||
| Statutory policyholders’ position | $ | 5,908 | $ | 5,740 | |||||||||||||
| Risk-to-capital | 9:6:0 | 10.0:1 | |||||||||||||||
MGIC Financial Strength Ratings | ||||||||||||||
| Rating Agency | Rating | Outlook | ||||||||||||
| Moody’s Investor Services | A2 | Stable | ||||||||||||
| Standard and Poor’s Rating Services | A- | Positive | ||||||||||||
| A.M. Best | A | Stable | ||||||||||||
MAC Financial Strength Ratings | ||||||||||||||
| Rating Agency | Rating | Outlook | ||||||||||||
| Standard and Poor's Rating Services | A- | Positive | ||||||||||||
| A.M. Best | A | Stable | ||||||||||||
| Share repurchases | ||||||||||||||||||||||||||||||||
| Period Beginning | Period Ending | Total number of shares purchased | Average price paid per share | Total number of shares purchased as part of publicly announced plans or programs | Approximate dollar value of shares that may yet be purchased under the programs (1) | |||||||||||||||||||||||||||
| January 1, 2026 | January 31, 2026 | 2,697,373 | $ | 27.12 | 2,697,373 | $ | 352,011,897 | |||||||||||||||||||||||||
| February 1, 2026 | February 28, 2026 | 2,251,029 | 26.75 | 2,251,029 | 291,807,028 | |||||||||||||||||||||||||||
| March 1, 2026 | March 31, 2026 | 2,260,367 | 26.19 | 2,260,367 | 232,603,858 | |||||||||||||||||||||||||||
| 7,208,769 | $ | 26.71 | 7,208,769 | |||||||||||||||||||||||||||||
| Exhibit Number | Description of Exhibit | Form | Exhibit(s) | Filing Date | |||||||||||||
| Certification of CEO under Section 302 of Sarbanes-Oxley Act of 2002 † | |||||||||||||||||
| Certification of CFO under Section 302 of Sarbanes-Oxley Act of 2002 † | |||||||||||||||||
| Certification of CEO and CFO under Section 906 of Sarbanes-Oxley Act of 2002 (as indicated in Item 6 of Part II, this Exhibit is not being “filed”) †† | |||||||||||||||||
| 101.INS | Inline XBRL Instance Document | ||||||||||||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | ||||||||||||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||||||||||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||||||||||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||||||||||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||||||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | ||||||||||||||||
| MGIC INVESTMENT CORPORATION | |||||
| /s/ Nathaniel H. Colson | |||||
| Nathaniel H. Colson | |||||
Executive Vice President and Chief Financial Officer | |||||
| /s/ Julie K. Sperber | |||||
| Julie K. Sperber | |||||
| Vice President, Controller and Chief Accounting Officer | |||||
| 1. | I have reviewed this quarterly report on Form 10-Q of MGIC Investment Corporation; | ||||
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | ||||
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | ||||
| 4. | The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have: | ||||
| a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |||||||
| b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |||||||
| c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |||||||
| d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and | |||||||
| 5. | The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions): | ||||
| a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and | |||||||
| b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. | |||||||
| 1. | I have reviewed this quarterly report on Form 10-Q of MGIC Investment Corporation; | ||||
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | ||||
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | ||||
| 4. | The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have: | ||||
| a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |||||||
| b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |||||||
| c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |||||||
| d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and | |||||||
| 5. | The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions): | ||||
| a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and | |||||||
| b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. | |||||||
| /s/ Timothy J. Mattke | ||
| Timothy J. Mattke | ||
| Chief Executive Officer | ||
| /s/ Nathaniel H. Colson | ||
| Nathaniel H. Colson | ||
| Chief Financial Officer | ||